Arca
Skip to content

Eikon Therapeutics, Inc.

4 private offerings reported to the SEC on Form D since 2016, $1.1B sold in all. Biotech, CA.

  • Form D offerings: 4
  • Reported sold: $1.1B
  • Newest: Feb 28, 2025

Every Form D Offering

Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
Feb 28, 2025$350.7M$400.0MEikon Therapeutics, Inc.Biotech · CANot amended0001861123-25-000001
Jun 1, 2023$140.8M$535.0MEikon Therapeutics, Inc.Biotech · CANot amended0001861123-23-000001
Jan 6, 2022$517.8M$525.0MEikon Therapeutics, Inc.Biotech · CANot amended0001861123-22-000001
May 13, 2021$102.5M$107.8MEikon Therapeutics, Inc.Biotech · CANot amended0001861123-21-000001

SEC Profile

From the company's EDGAR record
Ticker
EIKN
Business address
Millbrae, Ca
Incorporated in
DE
SEC industry
Biological Products, (No Diagnostic Substances)
All SEC filings
CIK 1861123 on EDGAR

A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.